Clinical Pharmacology · Pharmacokinetics
Half-Life and Steady State
On this page 6 sections
In 30 seconds
Half-life is the time it takes for a drug's blood concentration to fall by half, and it governs nearly everything about dosing schedules. Most drugs follow first-order kinetics, meaning a constant fraction (not a constant amount) is eliminated per unit time. After about four to five half-lives, a drug given repeatedly reaches steady state — the point where the amount going in per interval equals the amount leaving, so peaks and troughs plateau. Understanding this lets clinicians predict when a drug will start working, when it will fully leave the body, and how to use loading doses to skip the wait.
The college version
First-Order Kinetics and Elimination Half-Life
Elimination half-life (t½) is the time required for the plasma concentration of a drug to decrease by 50%. The vast majority of drugs are eliminated by first-order kinetics: the rate of elimination is proportional to the current concentration. Practically, this means a fixed percentage — not a fixed milligram amount — disappears every half-life. If a drug has a half-life of 6 hours and starts at 100 mg/L, it falls to 50 mg/L at 6 hours, 25 mg/L at 12 hours, 12.5 mg/L at 18 hours, and so on. Because the process is exponential, concentration never mathematically reaches zero, but clinically a drug is considered eliminated after about five half-lives (roughly 97% gone).
Zero-Order Kinetics
A small but clinically important group of drugs — classic examples include ethanol, phenytoin at high doses, and aspirin in overdose — follow zero-order kinetics. Here, the elimination pathway (usually an enzyme system) becomes saturated, so a constant amount per unit time is eliminated regardless of concentration. This is dangerous because small dose increases can cause disproportionately large rises in blood level, since the body's clearance capacity is capped. Zero-order kinetics also means "half-life" is not a fixed, meaningful number for these drugs the way it is for first-order drugs.
Reaching Steady State: The Four-to-Five Half-Life Rule
When a drug is given repeatedly at a fixed dose and interval, concentration rises with each dose because some of the previous dose is still present when the next one arrives. Steady state is reached when the amount of drug eliminated between doses equals the amount administered, so the peak and trough levels stop changing from one cycle to the next. For a first-order drug, this equilibrium is reached after approximately four to five half-lives, regardless of the dose size or the dosing interval — a larger dose produces a higher steady-state concentration, but it does not get there any faster. This same four-to-five half-life rule applies in reverse: after stopping a drug, it takes four to five half-lives to be essentially washed out of the body. This is why drugs are tapered or why interacting medications must be separated by an appropriate washout period.
Loading Doses versus Maintenance Doses
Waiting four to five half-lives for a drug to reach a therapeutic level can be clinically unacceptable — for example, in a patient with a life-threatening arrhythmia. A loading dose is a single larger initial dose designed to rapidly achieve a therapeutic concentration without waiting through multiple half-lives. After the loading dose, smaller maintenance doses are given at regular intervals simply to replace what is eliminated, keeping the concentration within the therapeutic range. Drugs with long half-lives (such as digoxin or amiodarone) are the ones most likely to require a loading dose, because their natural time to steady state would otherwise be days to weeks.
Peak and Trough Levels and Therapeutic Drug Monitoring
The peak level is the highest concentration reached after a dose (timing depends on the route and absorption rate), and the trough is the lowest concentration, drawn immediately before the next scheduled dose. Therapeutic drug monitoring (TDM) uses these measured levels to keep a drug within its therapeutic window — high enough to be effective, low enough to avoid toxicity. TDM matters most for drugs with a narrow therapeutic index, meaning the effective dose and the toxic dose are close together; common examples include vancomycin, aminoglycosides, lithium, and certain anticonvulsants. A trough that's too high suggests accumulation and risk of toxicity, while a trough that's too low suggests the dose or interval isn't adequate.
Dosing Interval and Fluctuation
The dosing interval relative to the half-life determines how much the concentration swings between peak and trough at steady state. Dosing more frequently than the half-life produces smaller peak-to-trough swings (a smoother concentration curve), while dosing less frequently produces larger fluctuation — a higher peak and a lower trough. Extended-release formulations exploit this by slowing absorption so the effective dosing interval feels shorter relative to the drug's elimination, smoothing out fluctuation without changing how often a patient swallows a pill. Clinicians choose intervals that balance convenience, adherence, and keeping the concentration within the therapeutic window at every point in the cycle.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine you have a full glass of juice, and every hour exactly half of what's left evaporates. First hour: half is gone. Next hour: half of what remained is gone. It keeps shrinking by half, half, half — that "half the time" is the drug's half-life. Now imagine instead of just watching it evaporate, someone keeps pouring a little more juice in on a schedule, like every hour. At first the glass level jumps around a lot, but after pouring in about four or five times, the amount poured in each time matches the amount that evaporates in between pours — so the glass settles into a steady up-and-down pattern that doesn't grow or shrink overall anymore. That settled pattern is "steady state." If you're in a hurry and don't want to wait through all those pours to get the glass full, you could just dump in one big splash at the start (a "loading dose") and then keep topping it off with smaller regular pours (the "maintenance dose") to stay right where you want it.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient is started on a long-half-life drug with no loading dose and a fixed daily maintenance dose. The nurse expects to see the drug's clinical effect appear gradually over several days rather than immediately. Why does this happen?
Show answer
It takes several half-lives to build up to a steady, therapeutic concentration.
Without a loading dose, the drug only rises gradually with each maintenance dose, and a long half-life means each of those steps takes a long time — so it takes roughly four to five half-lives (which, for a long-half-life drug, can be days) before the concentration plateaus at a level high enough to produce the full clinical effect.
A patient on a narrow-therapeutic-index antibiotic has a trough level drawn just before the next dose that comes back higher than the target range, even though the peak levels look appropriate. What does this trend in the trough suggest is happening, and what is one general way the regimen might be adjusted?
Show answer
The rising trough suggests the drug is accumulating between doses, and the dose should be reduced or the interval lengthened.
Since peaks look fine but troughs are creeping up, the body isn't clearing enough drug before the next dose arrives, meaning levels are stacking up over time; a common fix is to lower the dose, lengthen the interval, or both, then recheck levels to confirm they've come back within the target range.
Quick check
3 questions here. Answers stay hidden until you check.
Approximately how many half-lives are required for a drug given at a fixed dose and interval to reach steady state?
Which best describes zero-order kinetics?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

